sequence4_hypersensitivity type 4&5.pptx

Upload: chocoholic-potchi

Post on 30-May-2018

220 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/14/2019 sequence4_hypersensitivity type 4&5.pptx

    1/28

    Cell mediated hypersensitivityor Delayed hypersensitivity

    Type IV Hypersensitivity

  • 8/14/2019 sequence4_hypersensitivity type 4&5.pptx

    2/28

    ;It is mediated by cells circulatingantibody and complement are not.involved Many reactions to

    immunologic insult involve both.cellular and humoral components It is mediated by soluble factors

    ( )lymphokines released by the

    .sensitized T lymphocytes The

    lymphokines have biologicalactivities affecting various cell

    .types

    Type IV Hypersensitivity

  • 8/14/2019 sequence4_hypersensitivity type 4&5.pptx

    3/28

    Those that may be used as examples ofdelayed type hypersensitivity

    :response includes

    Tuberculin skin reaction Contact sensitivity Granulomatous hypersensitivity

    Type IV Hypersensitivity

  • 8/14/2019 sequence4_hypersensitivity type 4&5.pptx

    4/28

    This form of hypersensitivity was.originally described by Koch

    The skin reaction is frequently used

    to test for sensitivity to theorganisms following previous.exposure

    This form of hypersensitivity may

    -also be induced by non microbial,antigens such as beryllium and.zirconium

    Tuberculin-type Hypersensitivity

  • 8/14/2019 sequence4_hypersensitivity type 4&5.pptx

    5/28

    The tuberculin skin test reaction.principally involves monocytes

    The tuberculin skin test is an

    example of the recall response tosoluble antigen previously.encountered during infection

    Tuberculin-type Hypersensitivity

  • 8/14/2019 sequence4_hypersensitivity type 4&5.pptx

    6/28

    -Tuberculin like delayed type( )hypersensitivity DTH reactions are

    .used practically in two ways

    ,First reaction to soluble

    antigens from a pathogendemonstrates past infection with

    .that pathogen Thus tuberculin

    reactivity confirms pastinfection with . ,M tuberculosisbut not necessarily active

    .disease

    Tuberculin-type Hypersensitivity

  • 8/14/2019 sequence4_hypersensitivity type 4&5.pptx

    7/28

    ,Second DTH responses to frequentlyencountered microbes are a general

    - .measure of cell mediated immunity This can be tested with intradermal

    injection of single antigens from common,pathogens or a multipuncture devicewhich delivers seven common microbial

    .antigens in a standardized fashion

    Loss of recall responses to specific

    antigens occurs in a wide range of-diseases and infections which impair T

    ,cell function and during therapy withcorticosteroids or immunosuppressive

    .agents

    Tuberculin-type Hypersensitivity

  • 8/14/2019 sequence4_hypersensitivity type 4&5.pptx

    8/28

    Contact hypersensitivity ischaracterized by an eczematous

    reaction at the point of contact.with the allergen

    It is often seen following contact, ,with agents such as nickel chromate

    rubber accelerators and.pentadecacatechol

    Contact with irritants that damageskin by toxic mechanisms notmediated by hypersensitivity can

    .also produce eczema

    Contact hypersensitivity

  • 8/14/2019 sequence4_hypersensitivity type 4&5.pptx

    9/28

    The Langerhans cell is the principal-antigen presenting cell

    Contact hypersensitivity is primarily

    ,an epidermal reaction and the ,dendritic Langerhans cell located,in the suprabasal epidermis is the

    -principal antigen presenting cell

    ( ) . APC involved Langerhans cells are,inactivated by ultraviolet B whichcan thus prevent or alleviate the

    .effects of contact hypersensitivity

    Contact hypersensitivity

  • 8/14/2019 sequence4_hypersensitivity type 4&5.pptx

    10/28

    ,In vitro Langerhans cells act asAPCs and are more potent in this

    . regard than monocytes Langerhans-cells take up hapten modified

    proteins by micropinocytosis and-under the influence of interleukin 1

    ( - ) ( )IL 1 and tumor necrosis factor TNF

    from keratinocytes and other cells

    ,undergo maturation increase the-expression of MHC and co stimulatory

    molecules and migrate to draining

    .lymph nodes

    Contact hypersensitivity

  • 8/14/2019 sequence4_hypersensitivity type 4&5.pptx

    11/28

    Keratinocytes produce a range ofcytokines important to the contact

    .hypersensitivity - ,IL 3 can activate Langerhans cells

    - ,co stimulate proliferative responsesrecruit mast cells and induce thesecretion of immunosuppressive.cytokines These latter dampen the

    immune response and induce the.clonal anergy in TH1 cells

    Contact hypersensitivity

  • 8/14/2019 sequence4_hypersensitivity type 4&5.pptx

    12/28

    Keratinocytes can be activated by a,number of stimuli including

    .allergens and irritants Activatedkeratinocytes produce

    immunostimulatory cytokines such asTNF - -and granulocyte macrophage

    - ( - )colony stimulating factor GM CSF

    .which activate Langerhans cells

    Contact hypersensitivity

  • 8/14/2019 sequence4_hypersensitivity type 4&5.pptx

    13/28

    A contact hypersensitivity reaction:has two stages sensitization and

    allicitation

    Sensitization produces a

    population of memory T cells Elicitation involves recruitment

    +of CD4 lymphocytes and

    monocytes

    Contact hypersensitivity

  • 8/14/2019 sequence4_hypersensitivity type 4&5.pptx

    14/28

    Sensitization takes 10 14 days in. ,humans Once absorbed the hapten

    with a protein and is internalized ,by epidermal Langerhans cells which

    leave the epidermis and migrates asveiled cells through the afferent

    lymphatics to the paraoctical areas.of regional lymph nodes Here they

    -present hapten protien conjugates to+ ,CD4 lymphocytes producing a

    + .population of memory CD4 T cells

    Sensitization

  • 8/14/2019 sequence4_hypersensitivity type 4&5.pptx

    15/28

    Langerhans cells carrying the hapten(carrier complex 1)move from the

    ,epidermis to the dermis where they-present the hapten carrier complex to

    + (memory CD4 T cells 2) Activated+CD4 T cells released IFN, which

    - (induces expression of ICAM 1 3) and(later MHC class II molecules 4) on

    the surface of keratinocytes and onthe endothelial cells of dermal

    capillaries and activates

    -, -keratinocytes such as IL 1 IL 6 and

    -GM CSF

    Elicitation

  • 8/14/2019 sequence4_hypersensitivity type 4&5.pptx

    16/28

    (5) +Non antigen specific CD4 T cellsare attracted to the site by

    (cytokinesis 6) and may bind to-keratinocytes via ICAM 1 and class II

    .molecules Activates macrophages are,also attracted to the skin but this.occurs later Thereafter the reaction

    .stars to downregulate This

    doenregulation may be influenced by,eicosanoids such as PGE produced byactivated keratinocytes and

    (macrophages 7) has been shown to-induce a specific inhibitor of IL 1

    activity

    Elicitation

  • 8/14/2019 sequence4_hypersensitivity type 4&5.pptx

    17/28

    Granulomatous hypersensitivity isclinically the most important form of

    ,TYPE IV hypersensitivity and causesmany of the pathological effects in

    disease that involves T cells mediated.immunity It usually results from the persistence

    within macrophages of intracellular

    microorganisms or other particles that.the cells is unable to destroy Thisprocess results in epithelioid cell

    .granuloma formation This histologicalappearance of the granuloma reaction is

    quite different from that of the-

    GRANULOMATOUS HYPERSENSITIVTY

  • 8/14/2019 sequence4_hypersensitivity type 4&5.pptx

    18/28

    ,However they often result fromsensitization to similar microbial

    .antigens Immunological granulomaformation also occurs in the sensitivity

    ,reactions to zirconium and beryllium and,in sarcoidosis although in the latter the.antigen is unknown

    Foreign body granuloma formation occur with,talc silica and a variety of other

    .particulate agents In this casemacrophages are unable to digest the.inorganic matter These non immunological

    granulomas may be distinguished by the.absence of lymphocytes in the lesion

    GRANULOMATOUS HYPERSENSITIVTY

  • 8/14/2019 sequence4_hypersensitivity type 4&5.pptx

    19/28

    An immunological granuloma typicallyhas a core of epithelioid cells and

    ,macrophages sometimes with giant. ,cells In some diseases such as

    ,tuberculosis this central area may,have a zone of necrosis with

    complete destruction of all cellular.architecture The

    /macrophage epithelioid core is,surrounded by a cuff of lymphocytes

    and there may also be considerable

    fibrosis caused by proliferation of

    fibroblasts and increased collagen

    GRANULOMATOUS HYPERSENSITIVTY

  • 8/14/2019 sequence4_hypersensitivity type 4&5.pptx

    20/28

    DELAYED HYPERSENSITIVITYREACTIONS

    Type Reaction

    time

    Clinical

    appearance

    Histology Antigen

    contact 48-72 hr Eczema Lymphocytes,latermacrophages,

    oedema ofepidermidis

    Epidermal e.g.nickel, rubber,poison ivy

    tuberculin 48-72 hr Local induration Lymphocytes,monocytes,macrophages

    Intradermal e.g.tuberculin

    granuloma 21-28 days Hardening e.g.

    skin or lungs

    Macrophages,

    epithelioid cells,giant cells,fibrosis

    Persistent Ag or

    Ag/Abcomplexes ornon-immunoglobine.g. talc

  • 8/14/2019 sequence4_hypersensitivity type 4&5.pptx

    21/28

    Receptor mediated hypersensitivity

    Type V Hypersensitivity

  • 8/14/2019 sequence4_hypersensitivity type 4&5.pptx

    22/28

    This reaction occur when IgGclass antibodies directed

    towards cell surfaces antigens

    have either a stimulating orinhibitory effect on their.target

    Cells are signaled by agents such, -as hormones mainly amino acid

    :based hormones These hormones cannot pass through

    plasma membranes because they are

    Type V Hypersensitivity

  • 8/14/2019 sequence4_hypersensitivity type 4&5.pptx

    23/28

    Type V hypersensitivity has beenadded as a distinction from Type

    .II

    This additional class of reactionrefers to stimulatory,hypersensitivity where instead

    of binding to cell surface

    components and destroying the,cells IgG receptors thus either,prevents ligand binding or

    mimics the effect of the

    ,endogenous ligand thus impairing

    Type V Hypersensitivity

  • 8/14/2019 sequence4_hypersensitivity type 4&5.pptx

    24/28

    This is a useful distinction to TypeII reactions where the cytotoxic

    binding of antibody causes cell

    .death

    Stimulatory hypersensitivity occurswhen the autoantibodies cause

    inappropriate stimulation of the

    .cell

    Type V Hypersensitivity

  • 8/14/2019 sequence4_hypersensitivity type 4&5.pptx

    25/28

    Colby C. Evans, M.D.

    John D. Fleming, M.B., B.S

    New England Journal of MedicineAugust 2008

    Allergic Contact Dermatitis

    from a Henna Tattoo

  • 8/14/2019 sequence4_hypersensitivity type 4&5.pptx

    26/28

    Temporary henna tattooing is a custom.at weddings in much of the world The

    ( )dyeing agent hennotannic acid

    .rarely leads to skin sensitization,However tattoo henna is often mixed

    ( )with paraphenylenediamine PPD to.hasten drying and darken the color

    PPD is a common allergen that is.also found in permanent hair dyes

    Allergic Contact Dermatitis from a HennaTattoo

  • 8/14/2019 sequence4_hypersensitivity type 4&5.pptx

    27/28

    Allergens that cause reactions inpatients who are sensitive to PPD

    include sunscreens containing

    ,aminobenzoic acid certain local, .anesthetics and sulfonamides -The patient was treated high potency

    ,topical corticosteroids and the

    ,lesions resolved although withextensive postinflammatory.hyperpigmentation

    Allergic Contact Dermatitis from aHenna Tattoo

  • 8/14/2019 sequence4_hypersensitivity type 4&5.pptx

    28/28

    Allergic Contact Dermatitis from aHenna Tattoo